Abstract

Tuberculosis disease continues to contribute to the mortality burden globally. Due to the several shortcomings of the available diagnostic methods, tuberculosis disease continues to spread. The difficulty to obtain sputum among the very ill patients and the children also affects the quick diagnosis of tuberculosis disease. These challenges warrant investigating different sample types that can provide results in a short time. Highlighted in this review are the approved pulmonary tuberculosis diagnostic methods and ongoing research to improve its diagnosis. We used the PRISMA guidelines for systematic reviews to search for studies that met the selection criteria for this review. In this review we found out that enormous biosignature research is ongoing to identify host biomarkers that can be used as predictors of active PTB disease. On top of this, more research was also being done to improve already existing diagnostic tests. Host markers required more optimization for use in different settings given their varying sensitivity and specificity in PTB endemic and non-endemic settings.

MeSH

Tuberculosis, Pulmonary, Biomarkers, Tuberculosis, Immunity, Diagnosis, Research, Tuberculosis Disease

Cited by

• A Health Survey Revealing Prevalence of Vector-Borne Diseases and Tuberculosis in Papua New Guinea Defence Force Personnel and Families. Am J Trop Med Hyg, 2023
• Correlation of serum Adenosine Deaminase levels with microbiological parameters in Pulmonary Tuberculosis. Indian J Clin Biochem, 2024
• Omics Biomarkers for Monitoring Tuberculosis Treatment: A Mini-Review of Recent Insights and Future Approaches. Infect Drug Resist, 2022
• Diagnostic yield of induced sputum and Bronchoalveolar lavage in suspected pulmonary tuberculosis. BMC Infect Dis, 2025
• CLINICALLY RELEVANT METALLIC NANOPARTICLES IN TUBERCULOSIS DIAGNOSIS AND THERAPY. Adv Ther (Weinh), 2025
• Tuberculous meningitis diagnosis and treatment: classic approaches and high-throughput pathways. Front Immunol, 2025